Cancer Capital (CNCL) 10-Q 3 Aug 23 2023 Q2 Quarterly report Financial data

Cover

Cover	6 Months Ended
	Jun. 30, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-32363
Entity Registrant Name	CANCER CAPITAL CORP.
Entity Central Index Key	0001130889
Entity Tax Identification Number	91-1803648
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	2157 S. Lincoln Street
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Salt Lake City
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84106
City Area Code	(801)
Local Phone Number	323-2395
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	true

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash	$ 16,456	$ 22,055
Total current assets	16,456	22,055
TOTAL ASSETS	16,456	22,055
CURRENT LIABILITIES
Accounts payable – related party	9,000	6,000
Notes payable – related party	155,125	155,125
Notes payable	130,275	130,275
Accrued interest – related party	83,886	77,680
Accrued interest	69,785	64,574
Total current liabilities	448,071	433,654
Total liabilities	448,071	433,654
STOCKHOLDERS' DEFICIT
Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding	6,150	6,150
Additional paid-in capital	47,050	47,050
Accumulated deficit	(484,815)	(464,799)
Total stockholders' deficit	(431,615)	(411,599)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 16,456	$ 22,055

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	20,000,000	20,000,000
Common Stock, Shares, Issued	6,150,000	6,150,000
Common Stock, Shares, Outstanding	6,150,000	6,150,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenues
Operating expenses
General and administrative	2,899	2,850	8,599	11,960
Total operating expenses	2,899	2,850	8,599	11,960
Loss from operations	(2,899)	(2,850)	(8,599)	(11,960)
Other expense
Interest expense – related party	(3,103)	(2,903)	(6,206)	(5,805)
Interest expense	(2,606)	(2,505)	(5,211)	(4,691)
Total other expense	(5,709)	(5,408)	(11,417)	(10,496)
Loss before income taxes	(8,608)	(8,258)	(20,016)	(22,456)
Income tax expense
Net loss	$ (8,608)	$ (8,258)	$ (20,016)	$ (22,456)
Net loss per share – Basic and diluted	$ 0	$ 0	$ 0	$ 0
Weighted average shares outstanding – Basic and diluted	6,150,000	6,150,000	6,150,000	6,150,000

Condensed Statements of Stockho

Condensed Statements of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance – December 31, 2022 at Dec. 31, 2021	$ 6,150	$ 47,050	$ (422,332)	$ (369,132)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	6,150,000
Net loss			(14,198)	(14,198)
Balance – June 30, 2023 at Mar. 31, 2022	$ 6,150	47,050	(436,530)	(383,330)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	6,150,000
Balance – December 31, 2022 at Dec. 31, 2021	$ 6,150	47,050	(422,332)	(369,132)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	6,150,000
Net loss				(22,456)
Balance – June 30, 2023 at Jun. 30, 2022	$ 6,150	47,050	(444,788)	(391,588)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	6,150,000
Balance – December 31, 2022 at Mar. 31, 2022	$ 6,150	47,050	(436,530)	(383,330)
Shares, Outstanding, Beginning Balance at Mar. 31, 2022	6,150,000
Net loss			(8,258)	(8,258)
Balance – June 30, 2023 at Jun. 30, 2022	$ 6,150	47,050	(444,788)	(391,588)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	6,150,000
Balance – December 31, 2022 at Dec. 31, 2022	$ 6,150	47,050	(464,799)	(411,599)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022	6,150,000
Net loss			(11,408)	(11,408)
Balance – June 30, 2023 at Mar. 31, 2023	$ 6,150	47,050	(476,207)	(423,007)
Shares, Outstanding, Ending Balance at Mar. 31, 2023	6,150,000
Balance – December 31, 2022 at Dec. 31, 2022	$ 6,150	47,050	(464,799)	(411,599)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022	6,150,000
Net loss				(20,016)
Balance – June 30, 2023 at Jun. 30, 2023	$ 6,150	47,050	(484,815)	(431,615)
Shares, Outstanding, Ending Balance at Jun. 30, 2023	6,150,000
Balance – December 31, 2022 at Mar. 31, 2023	$ 6,150	47,050	(476,207)	(423,007)
Shares, Outstanding, Beginning Balance at Mar. 31, 2023	6,150,000
Net loss			(8,608)	(8,608)
Balance – June 30, 2023 at Jun. 30, 2023	$ 6,150	$ 47,050	$ (484,815)	$ (431,615)
Shares, Outstanding, Ending Balance at Jun. 30, 2023	6,150,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities
Net Loss	$ (20,016)	$ (22,456)
Adjustment to reconcile net loss to cash used by operating activities:
Expenses paid by related party	3,000	3,000
Changes in operating assets and liabilities:
Accounts payable		1,350
Increase in accrued interest – related party	6,206	5,806
Increase in accrued interest	5,211	4,691
Net cash used by operating activities	(5,599)	(7,609)
Cash Flows from Investing Activities
Net cash provided by investing activities
Cash Flows from Financing Activities
Proceeds from notes payable		28,000
Net cash provided by financing activities
Increase (decrease) in cash	(5,599)	20,391
Cash at beginning of period	22,055	62
Cash at end of period	16,456	20,453
Supplemental Cash Flow Information:
Cash paid for interest
Cash paid for income taxes

NOTE 1 - BASIS OF FINANCIAL STA

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION	NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its December 31, 2022 Annual Report on Form 10-K. Operating results for the six months ended June 30, 2023 are not necessarily indicative of the results to be expected for year ending December 31, 2023.

NOTE 2 _ GOING CONCERN

NOTE 2 – GOING CONCERN	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NOTE 2 – GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies.

NOTE 3 _ RELATED PARTY TRANSACT

NOTE 3 – RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
NOTE 3 – RELATED PARTY TRANSACTIONS	NOTE 3 – RELATED PARTY TRANSACTIONS During the six months ended June 30, 2023, a shareholder invoiced the Company for consulting, administrative and professional services and out-of-pocket costs provided or paid on behalf of the Company totaling $ 3,000 3,000 9,000 6,000 A shareholder loaned the Company funds in prior years. The notes bear interest at 8 155,125 155,125 83,886 77,680

NOTE 4 _ NOTES PAYABLE

NOTE 4 – NOTES PAYABLE	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
NOTE 4 – NOTES PAYABLE	NOTE 4 – NOTES PAYABLE During the six months ended June 30, 2023 and 2022, the Company was loaned $ 0 28,000 8 130,275 130,275 69,785 64,574

NOTE 5 _ SUBSEQUENT EVENTS

NOTE 5 – SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
NOTE 5 – SUBSEQUENT EVENTS	NOTE 5 – SUBSEQUENT EVENTS The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.

NOTE 3 _ RELATED PARTY TRANSA_2

NOTE 3 – RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Related Party Transactions [Abstract]
Costs and Expenses, Related Party	$ 3,000	$ 3,000
[custom:AccountsPayableRelatedPartiesCurrent1-0]	$ 9,000		$ 6,000
Debt Instrument, Interest Rate During Period	8%	8%
[custom:NotesPayableRelatedPartiesClassifiedCurrent1-0]	$ 155,125		155,125
Accrued Liabilities and Other Liabilities	$ 83,886		$ 77,680

NOTE 4 _ NOTES PAYABLE (Details

NOTE 4 – NOTES PAYABLE (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Debt Disclosure [Abstract]
Proceeds from Notes Payable		$ 28,000
Debt Instrument, Interest Rate During Period	8%	8%
Notes Payable, Current	$ 130,275		$ 130,275
Interest Payable, Current	$ 69,785		$ 64,574